Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2012
At a glance
- Drugs Docetaxel (Primary) ; Fluorouracil; Irinotecan
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 05 Jul 2012 Final results published in the British Journal of Cancer.
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History